(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

[4-(3,4-dimethylphenyl)piperazin-1-yl](3-methylphenyl)acetic acid, 250mg

3-Bromo-5-methylbenzoic acid methyl ester, 95.0%, 1g

4-Bromo-7-methoxyquinoline, 95.0%, 1g

Methyl 2,4,6-trimethylbenzenesulfonate, 97%, 5g

4-Hydroxyindole, 98.0%, 25g

3-(2,2,2-Trifluoroethoxy)aniline hydrochloride, 95+%, 5g

1,2-Di(pyrimidin-2-yl)disulfane, 95%, 1g

2,6-Dichloro-3-cyano-4-methylpyridine>98.0%(GC)25g

(R)-Hexahydropyrrolo[1,2-a]pyrazin-6(2H)-one hydrochloride, 95.0%, 50mg

3-(3-(4-chlorobenzyl)-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride, 95.0%, 250mg

Sodium Methacrylate (stabilized with MEHQ)>98.0%(T)100g

(2S,4S,5S)-1-(3,5-Di-tert-butylphenyl)-3-(2-methylnaphthalen-1-yl)-4,5-diphenyl-1,3,2-diazaphospholidine 2-oxide, 250mg